Search research articles
Contact Us
Filters
Showing results (91-100 of 289) with videos related to
Page
of 29
Sort By:
Frontiers in Oncology
|
September 9, 2020
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
August 29, 2015
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma
Roberto Iacovelli, Daniele Santini, Mimma Rizzo, et al.
Tumori
|
August 29, 2025
Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis
Marco Stellato, Ernesto Zecca, Paola Bracchi, et al.
Cancer Treatment Reviews
|
March 18, 2022
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations
Roberto Iacovelli, Chiara Ciccarese, Giuseppe Procopio, et al.
BJU International
|
March 13, 2012
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes
Tiziana Magnani, Riccardo Valdagni, Roberto Salvioni, et al.
Critical Reviews in Oncology/Hematology
|
July 4, 2016
Immunotherapy advances in uro-genital malignancies
Raffaele Ratta, Roberta Zappasodi, Daniele Raggi, et al.
Anticancer Research
|
November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer
Chiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
Cancers
|
July 25, 2019
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
Pierangela Sepe, Elena Verzoni, Patrizia Miodini, et al.
Critical Reviews in Oncology/Hematology
|
April 22, 2017
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel
Sergio Baldari, Giuseppe Boni, Roberto Bortolus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women
Emilio Bajetta, Giuseppe Procopio, Luigi Celio, et al.
Page
of 29
Search research articles
Search
Showing results (91-100 of 289) with videos related to
Sort By:
Page
of 29
Frontiers in Oncology
|
September 9, 2020
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
August 29, 2015
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma
Roberto Iacovelli, Daniele Santini, Mimma Rizzo, et al.
Tumori
|
August 29, 2025
Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis
Marco Stellato, Ernesto Zecca, Paola Bracchi, et al.
Cancer Treatment Reviews
|
March 18, 2022
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations
Roberto Iacovelli, Chiara Ciccarese, Giuseppe Procopio, et al.
BJU International
|
March 13, 2012
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes
Tiziana Magnani, Riccardo Valdagni, Roberto Salvioni, et al.
Critical Reviews in Oncology/Hematology
|
July 4, 2016
Immunotherapy advances in uro-genital malignancies
Raffaele Ratta, Roberta Zappasodi, Daniele Raggi, et al.
Anticancer Research
|
November 14, 2013
A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer
Chiara Paglino, Giuseppe Procopio, Roberto Sabbatini, et al.
Cancers
|
July 25, 2019
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
Pierangela Sepe, Elena Verzoni, Patrizia Miodini, et al.
Critical Reviews in Oncology/Hematology
|
April 22, 2017
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel
Sergio Baldari, Giuseppe Boni, Roberto Bortolus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2005
Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women
Emilio Bajetta, Giuseppe Procopio, Luigi Celio, et al.
Page
of 29